BioCentury
ARTICLE | Clinical News

4-OHT gel: Preliminary Phase II data

December 13, 2004 8:00 AM UTC

Preliminary data from a dose-ranging, double-blind, placebo-controlled, U.S. and European Phase II trial in 130 premenopausal women showed that transdermal administration of a 4mg dose of 4-OHT gel to...